Is low molecular weight heparin effective for the prevention of venous thromboembolism in hospitalized cancer patients?
The application of low molecular weight heparins is supported by strong evidence for reducing venous thromboembolism in hospitalized cancer patients without significantly increasing major bleeding risk.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24345885
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00